patient selection for treatment with ibrutinib in cll
Published 7 years ago • 3.2K plays • Length 6:48Download video MP4
Download video MP3
Similar videos
-
2:14
selecting patients for treatment with ibrutinib in cll
-
3:19
patient selection for upfront ibrutinib
-
3:22
treatment strategies with ibrutinib in cll
-
5:52
patient selection for cll treatment
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
2:06
the role of ibrutinib in the frontline treatment of young patients with cll
-
2:02
enhancing immunotherapy for cll patients with ibrutinib
-
12:22
bridging therapy with tenecteplase or alteplase in patients with large ischemic core
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:44
ibrutinib and fcr in cll irrespective of ighv mutation status
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
0:43
using acalabrutinib in cll patients with ibrutinib intolerance
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
14:12
abstract: single-agent ibrutinib 420mg induces durable responses in patients with cll
-
5:29
real-world support for ibrutinib as a treatment for high-risk cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
9:03
up-front ibrutinib versus fcr for patients with cll